<DOC>
	<DOCNO>NCT02391558</DOCNO>
	<brief_summary>Clinical evaluation noninvasive OCT Angiography use Zeiss OCT Prototype replace fluorescein angiography .</brief_summary>
	<brief_title>Clinical Evaluation Noninvasive OCT Angiography Using Zeiss OCT Prototype Compare Fluorescein Angiography</brief_title>
	<detailed_description>Fluorescein angiography ( FA ) standard generally accept method identify vascular feature retina , detect capillary dropout neovessel growth . Its value undeniable routine ophthalmological examination . However , require intravenous injection fluorescein , cause nausea , vomit , rarely , anaphylaxis death . New OCT angiography method detect , noninvasively red blood cell flow , therefore , identify well retinal vasculature . It crucial major interest evaluate clinical utility new methodology compare information one obtain fluorescein angiography .</detailed_description>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<criteria>All patient clinical indication fluorescein angiography clinical practice Subjects pacemaker similarly critical electronic device Subjects severe ocular medium opacity Subjects corneal abnormality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>